We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Travere Therapeutics
TVTX
$5.78B
| $1.74M | ﹤0.01% |
113,443
+15,542
| +16% | +$283K |
|
1977
ZipRecruiter
ZIP
$423M
| $1.74M | ﹤0.01% |
97,921
+984
| +1% | +$16.2K |
|
1978
Futu Holdings
FUTU
$15.3B
| $1.74M | ﹤0.01% |
+43,674
| New | +$1.86M |
|
1979
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.73M | ﹤0.01% |
179,126
+5,624
| +3% | +$58.4K |
|
1980
Stock Yards Bancorp
SYBT
$2.6B
| $1.73M | ﹤0.01% |
38,202
-1,021
| -3% | -$47.8K |
|
1981
Clearwater Paper
CLW
$376M
| $1.73M | ﹤0.01% |
55,256
+153
| +0.3% | +$4.94K |
|
1982
Reynolds Consumer Products
REYN
$5.59B
| $1.73M | ﹤0.01% |
61,079
+4,751
| +8% | +$132K |
|
1983
Weis Markets
WMK
$1.86B
| $1.72M | ﹤0.01% |
26,799
-389
| -1% | -$28.3K |
|
1984
Malibu Boats
MBUU
$567M
| $1.72M | ﹤0.01% |
29,307
+1,796
| +7% | +$101K |
|
1985
Movado Group
MOV
$841M
| $1.72M | ﹤0.01% |
64,027
-1,177
| -2% | -$30.8K |
|
1986
Ecovyst
ECVT
$1.14B
| $1.72M | ﹤0.01% |
149,680
+26,699
| +22% | +$291K |
|
1987
CRH
CRH
$66.8B
| $1.71M | ﹤0.01% |
+30,706
| New | +$1.53M |
|
1988
Clearfield
CLFD
$374M
| $1.71M | ﹤0.01% |
36,061
+441
| +1% | +$18.8K |
|
|
PRSU
1989
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $1.71M | ﹤0.01% |
63,508
-5,425
| -8% | -$121K |
|
|
SILK
1990
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.71M | ﹤0.01% |
52,540
+2,317
| +5% | +$84.6K |
|
1991
Arvinas
ARVN
$572M
| $1.71M | ﹤0.01% |
68,722
+2,665
| +4% | +$68.5K |
|
1992
Gulfport Energy Corp
GPOR
$2.88B
| $1.7M | ﹤0.01% |
16,168
+1,282
| +9% | +$119K |
|
1993
First Busey Corp
BUSE
$2.56B
| $1.7M | ﹤0.01% |
84,424
-2,361
| -3% | -$45.3K |
|
1994
Sweetgreen
SG
$642M
| $1.69M | ﹤0.01% |
131,599
+18,342
| +16% | +$170K |
|
1995
Nextpower Inc
NXT
$15.7B
| $1.69M | ﹤0.01% |
42,348
+5,784
| +16% | +$212K |
|
1996
Newmark Group
NMRK
$2.63B
| $1.68M | ﹤0.01% |
270,537
+47,093
| +21% | +$290K |
|
1997
Procept Biorobotics
PRCT
$1.17B
| $1.68M | ﹤0.01% |
47,544
+12,957
| +37% | +$428K |
|
1998
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $1.68M | ﹤0.01% |
124,676
+13,747
| +12% | +$178K |
|
1999
AstraZeneca
AZN
$250B
| $1.68M | ﹤0.01% |
+11,737
| New | +$1.73M |
|
2000
PC Connection
CNXN
$2.12B
| $1.68M | ﹤0.01% |
37,178
-446
| -1% | -$19.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.